Vice President of Investor Relations, Virta Health
$200-275k
+ Equity + Bonus
More information about location
Diabetes reversal treatment
Be an early applicant
Diabetes reversal treatment
501-1000 employees
Be an early applicant
$200-275k
+ Equity + Bonus
More information about location
501-1000 employees
Company mission
To reverse diabetes and obesity in one billion people.
Role
Who you are
- 10+ years of experience in investor relations, finance, equity research, or investment banking
- Exceptional written and verbal communication skills; ability to translate financial data into compelling narratives
- Track record of managing investor relations for a high-growth or pre-IPO company (healthcare/tech strongly preferred)
- Strong knowledge of capital markets, financial modeling, and valuation methodologies
- Executive presence and comfort interfacing with senior leaders, investors, and analysts
- You put people first and take care of yourself, your peers, and our patients equally
- You have a strong sense of ownership and take initiative while empowering others to do the same
- You prioritize positive impact over busy work
- You have no ego and understand that everyone has something to bring to the table regardless of experience
- You appreciate transparency and promote trust and empowerment through open access of information
- You are evidence-based and prioritize data and science over seniority or dogma
- You take risks and rapidly iterate
What the job involves
- We’re looking for a strategic and investor-savvy professional to lead Virta’s investor relations function
- This is a unique opportunity to shape the external financial narrative for one of the most transformative companies in digital health
- As the Vice President, Investor Relations, you’ll work directly with the CFO and executive team to build meaningful relationships with investors, communicate our performance and vision to the market, and support Virta’s growth as we scale
- If you’re energized by translating complex financials into compelling stories and engaging with the investment community, this is the role for you
- Develop and execute a strategic investor relations (IR) program aligned with Virta’s financial and long-term goals
- Serve as the primary liaison between Virta and the investment community, including institutional investors and analysts
- Lead the creation of investor materials such as earnings presentations, Q&A scripts, investor decks, and quarterly updates
- Partner closely with Finance, Legal, and Communications on earnings preparation, regulatory filings, and disclosures
- Monitor market trends, peer performance, and investor sentiment to inform leadership and refine IR strategy
- Organize and lead investor meetings, non-deal roadshows, and industry conferences
- Provide feedback to executive leadership on market perceptions, valuation trends, and strategic opportunities
- Ensure compliance with SEC and regulatory standards as needed (especially in pre-IPO or IPO contexts)
- Within your first 90 days at Virta, we expect you will do the following:
- Gain deep understanding of Virta’s business model, financials, and long-term strategy
- Conduct a comprehensive audit of existing IR materials, tools, and communications
- Build relationships with key investors, analysts, and cross-functional internal stakeholders
- Design an IR strategy roadmap tailored to Virta’s stage and strategic goals
- Lead or co-lead Virta’s next investor update, incorporating best practices and strategic storytelling
- Set up systems to track investor feedback, sentiment, and competitive intelligence
Our take
Much of the care for type 2 diabetes has been based on control and prevention, rather than a direct reversal of the issue. Virta Health is changing that, providing patients with personalized treatment plans, virtual monitoring and patient care.
Instead of depending upon medication, which often needs to be increased over time, the company is tackling the problem at its root and taking a fundamentally different approach that is better for the patient, and more economical for insurers. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal.
While platforms like Vida Health also serve similar markets, the large number of prediabetic (88M) and diabetic (30M) Americans presents a significant opportunity for growth. Along with its significant funding round in 2021 fueling its efforts to expand the reach of its telehealth-powered diabetes reversal treatment. Positioning the company for widespread adoption and continued success in addressing this critical healthcare challenge.
Steph
Company Specialist at Welcome to the Jungle
Insights
4% employee growth in 12 months
Company
Funding (last 2 of 5 rounds)
Apr 2021
$133m
SERIES E
Dec 2020
$65m
SERIES D
Total funding: $373m
Company benefits
- Remote-first work environment with ability to work from home
- Flexible work hours & time off policy
- Virta pays 99% of all employee health insurance premiums, and 75% for all dependents
- Up to 16 weeks paid parental leave
- Enroll in the Virta treatment for free and give a discount to friends and family
- Internet, home office, learning & development stipends
- Employee Resource Groups like Parents of Virta, Ladies of Virta, and Virtans for DEI
- 401K and ROTH contribution opportunities
Company HQ
Civic Center, Denver, CO
Leadership
Sami Inkinen
(Co-Founder & CEO)Worked on Microsoft’s strategy team for MS Office, and as a consultant for McKinsey & Company within the software, telecommunications, and government sectors. Co-founder of online real estate marketplace Trulia, serving as its COO until its IPO and eventual sale to Zillow Group.
Share this job
View 9 more jobs at Virta Health